Inhibition of Swine Leukocyte Antigen-I Presentation in Transgenic Mini-pig Cell Lines by Expressing Human Cytomegalovirus US6

2010 ◽  
Vol 42 (10) ◽  
pp. 4648-4650 ◽  
Author(s):  
J.Y. Yoo ◽  
K.M. Choi ◽  
S.P. Hong ◽  
S.H. Kim ◽  
K.-W. Park ◽  
...  
2008 ◽  
Vol 20 (1) ◽  
pp. 176
Author(s):  
J. Y. Yoo ◽  
K. M. Choi ◽  
S. P. Hong ◽  
G. S. Han ◽  
E. J. Kim ◽  
...  

The CD8+ cytotoxic T lymphocyte (CTL)-mediated immune response is important in porcine xenotransplantation, and pigs could be used as a good model for organ donor if these immunological barriers are overcome. Human cytomegalovirus (HCMV) encodes unique short (US) 11 gene, which interferes with cellular immune responses by inducing rapid degradation of newly synthesized heavy chains of major histocompatibility (MHC) class I. The destruction of heavy chains by US11 helps the virus to hide from recognition by cytotoxic T lymphocytes at early stage. In this study we demonstrated the inhibitory effect of US11 on the cytotoxicity of CTL cells by down-regulation of swine leukocyte antigen (SLA)-I expression. We established five US11 clonal cell lines by transfection into minipig fetal fibroblasts and confirmed the integration of US11 gene by PCR and Southern blot assay. The reduction of SLA-I, which was expressed on the cell surface, was also detected by flow cytometry assay. The level (14.6% to 21.2%) of SLA-1 expression in US11 clonal cell lines was decreased relative to that in the control. In the CTL assay, the rate of CD8+ T cell-mediated cytotoxicity was significantly reduced to 31.9 � 11.3%, compared to that of the control (81.4 � 5.3%; P < 0.01; n = 4). These results indicate that HCMV viral protein US11 can effectively suppress the presentation of SLA-I in pig fetal fibroblast cells. This work was supported by a grant (Code # 20070101034005) from the BioGreen 21 Program, Rural Development Administration, Republic of Korea.


2000 ◽  
Vol 69 (Supplement) ◽  
pp. S384
Author(s):  
Hitomi Sasaki ◽  
Xiao-Chun Xu ◽  
Bashoo Naziruddin ◽  
Toru Higuchi ◽  
Douglas M. Smith ◽  
...  

Genes ◽  
2016 ◽  
Vol 7 (7) ◽  
pp. 36 ◽  
Author(s):  
Xiaoyu Huang ◽  
Qiaoli Yang ◽  
Junhu Yuan ◽  
Lixia Liu ◽  
Wenyang Sun ◽  
...  

2015 ◽  
Vol 14 (4) ◽  
pp. 15256-15266 ◽  
Author(s):  
Z.Z. Liu ◽  
J.H. Xia ◽  
L.L. Xin ◽  
Z.G. Wang ◽  
L. Qian ◽  
...  

2008 ◽  
Vol 82 (14) ◽  
pp. 7059-7077 ◽  
Author(s):  
Rebecca L. Sanders ◽  
Charles L. Clark ◽  
Christopher S. Morello ◽  
Deborah H. Spector

ABSTRACT The human cytomegalovirus (HCMV) IE2 86 protein is essential for viral replication. Two other proteins, IE2 60 and IE2 40, which arise from the C-terminal half of IE2 86, are important for later stages of the infection. Functional analyses of IE2 86 in the context of the infection have utilized bacterial artificial chromosomes as vectors to generate mutant viruses. One limitation is that many mutations result in debilitated or nonviable viruses. Here, we describe a novel system that allows tightly controlled temporal expression of the IE2 proteins and provides complementation of both growth-impaired and nonviable IE2 mutant viruses. The strategy involves creation of cell lines with separate lentiviruses expressing a bicistronic RNA with a selectable marker as the first open reading frame (ORF) and IE2 86, IE2 60, or IE2 40 as the second ORF. Induction of expression of the IE2 proteins occurs only following DNA recombination events mediated by Cre and FLP recombinases that delete the first ORF. HCMV encodes Cre and FLP, which are expressed at immediate-early (for IE2 86) and early-late (for IE2 40 and IE2 60) times, respectively. We show that the presence of full-length IE2 86 alone provides some complementation for virus production, but the correct temporal expression of IE2 86 and IE2 40 together has the most beneficial effect for early-late gene expression and synthesis of infectious virus. This approach for inducible protein translation can be used for complementation of other mutations as well as controlled expression of toxic cellular and microbial proteins.


2008 ◽  
Vol 131 (2) ◽  
pp. 160-169 ◽  
Author(s):  
Wei Wang ◽  
Ping Yu ◽  
Peng Zhang ◽  
Yujun Shi ◽  
Hong Bu ◽  
...  

2006 ◽  
Vol 58 (11) ◽  
pp. 873-882 ◽  
Author(s):  
Chak-Sum Ho ◽  
Erin S. Rochelle ◽  
Gregory W. Martens ◽  
Lawrence B. Schook ◽  
Douglas M. Smith

Sign in / Sign up

Export Citation Format

Share Document